Guofeng Zhou

1.0k citations
48 papers · 786 indexed · h-index 15
Topics
Hepatocellular Carcinoma Treatment and Prognosis (16 papers)Cancer, Hypoxia, and Metabolism (6 papers)Renal cell carcinoma treatment (5 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEAdvanced Functional Materials
Partner nations
ChinaUnited States

In The Last Decade

Guofeng Zhou

47 papers receiving 775 citations

Peers

Guofeng Zhou
Comparison fields: 5 of 89
  • Biomedical Engineering 259
  • Hepatology 216
  • Materials Chemistry 167
  • Biomaterials 166
  • Pulmonary and Respiratory Medicine 126
Replace Yujie Su with:
Yujie Su China
Yuanyi Zheng China
Yuan Yu China
Dexuan Xiao China
Sanshiro Hanada Japan
Shobha Regmi South Korea
Jingjie Hu United States
Leila Montazeri Iran
Juan Fan China
Guofeng Zhou relative to Yujie Su China Yujie Su's profile →
Citations per field
00.5×3.9×
Yujie Su · 1×
Citations per year

Countries citing papers authored by Guofeng Zhou

Since Specialization
Citations

This map shows the geographic impact of Guofeng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guofeng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guofeng Zhou more than expected).

Fields of papers citing papers by Guofeng Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guofeng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guofeng Zhou. The network helps show where Guofeng Zhou may publish in the future.

Co-authorship network of co-authors of Guofeng Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Guofeng Zhou. A scholar is included among the top collaborators of Guofeng Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guofeng Zhou. Guofeng Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 12
2 1
3 3
4 3
5 6
6 3
7 4
8 3
9 22
10 14
11 33
12 7
13 5
14 4
15 12
16 26
17 1
18 27
19 118
20 9

About Guofeng Zhou

Guofeng Zhou is a scholar working on Hepatology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 48 papers that have together received 786 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Renal cell carcinoma treatment (5 papers). The work is most often cited by research in Hepatology (216 citations), Biomaterials (166 citations) and Molecular Medicine (58 citations). Guofeng Zhou has collaborated with scholars based in China and United States. Frequent co-authors include Chuansheng Zheng, Xiangliang Yang, Yanbing Zhao, Gansheng Feng, Bin Xiong, Qing Du, Hui Zhao, Huibi Xu, Xuefeng Kan and Laisheng Chou. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Functional Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026